XETRA · BNN.DE
BRAIN Biotech AG
€2.78+€0.22 (+8.59%)
BRAIN Biotech AG’s quoted price sits in the lower half of its reported 52-week range, 28.53% below the high.
Loading market information…
XETRA · AAQ1.DE · EUR
Stock price, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
aap Implantate AG’s quoted price sits in the lower half of its reported 52-week range, 36.75% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow aap Implantate AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating as a medical technology firm, aap Implantate AG specializes in the development, manufacturing, and commercialization of orthopedic trauma devices. The company's market presence spans Germany, the United States, and various international regions. Its primary offerings feature LOQTEQ, an advanced anatomical plating system crucial for fracture treatment, in addition to a diverse selection of cannulated screws, conventional plates, and standard screws. Products are distributed under the 'aap' brand, reaching customers directly, including hospitals, purchasing syndicates, and hospital groups, as well as indirectly via its network of distributors. aap Implantate AG was founded in 1990 and maintains its corporate headquarters in Berlin, Germany.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€2.78+€0.22 (+8.59%)
BRAIN Biotech AG’s quoted price sits in the lower half of its reported 52-week range, 28.53% below the high.
€20.20+€0.20 (+1.0%)
MeVis Medical Solutions AG’s quoted price sits in the lower half of its reported 52-week range, 24.63% below the high.
€1.64+€0.06 (+3.81%)
NanoRepro AG’s quoted price sits in the lower half of its reported 52-week range, 31.88% below the high.
€0.92+€0.08 (+9.58%)
Maternus-Kliniken AG’s quoted price sits in the lower half of its reported 52-week range, 91.61% below the high.
€2.11-€0.07 (-3.21%)
Geratherm Medical AG’s quoted price sits in the lower half of its reported 52-week range, 55.01% below the high.
€7.40-€0.45 (-5.73%)
AS Latvijas Juras medicinas centrs’s quoted price sits in the lower half of its reported 52-week range, 19.57% below the high.
€0.28-€0.01 (-3.45%)
SynBiotic SE’s quoted price sits in the lower half of its reported 52-week range, 92.73% below the high.
A$0.08A$0.00 (0.0%)
Oakridge International Limited’s quoted price sits in the lower half of its reported 52-week range, 44.83% below the high.
